A world leader in gases, technologies and services for Industry and Health, Air Liquide is present in 80 countries with approximately 66,000 employees and serves more than 3.6 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the company’s activities since its creation in 1902.
Air Liquide’s ambition is to lead its industry, deliver long term performance and contribute to sustainability. The company’s customer- centric transformation strategy aims at profitable growth over the long term. It relies on operational excellence, selective investments, open innovation and a network organization implemented by the Group worldwide. Through the commitment and inventiveness of its people, Air Liquide leverages energy and environment transition, changes in healthcare and digitization, and delivers greater value to all its stakeholders.
Air Liquide’s revenue amounted to €21 billion in 2018 and its solutions that protect life and the environment represented more than 40% of sales. Air Liquide is listed on the Euronext Paris stock exchange (compartment A) and belongs to the CAC 40, EURO STOXX 50 and FTSE4Good indexes.
"Creative Oxygen", our signature
“Creative Oxygen” is the signature we use in all the countries where we operate. “Creative” embodies the endless inventiveness of Air Liquide’s teams. “Oxygen” references the history of Air Liquide. The Group has grown on the basis of oxygen; a vital resource for both industry and health. Over and above the molecule itself, oxygen is a source of inspiration for our teams to create new developments for our existing markets and for future business.
“Creative Oxygen” therefore refers to what we do, at the same time as embodying the inventiveness and creativity of our people. Since everyone is familiar with oxygen, our signature speaks to every audience. It supports our hundred-year-old brand and adds to its appeal by giving it a new impulse.